Assignee
RESVERLOGIX CORP
CA11 patents
Top patents by PatentIndex Score
US8053440B2Nov 8, 2011
Compounds for the prevention and treatment of cardiovascular diseases
RESVERLOGIX CORP53 citations97
US7846915B2Dec 7, 2010
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
RESVERLOGIX CORP33 citations90
US9610251B2Apr 4, 2017
Pharmaceutical compositions for substituted quinazolinones
RESVERLOGIX CORP12 citations76
US11407719B2Aug 9, 2022
Anti-inflammatory agents
RESVERLOGIX CORP1 citations72
US10882828B2Jan 5, 2021
Anti-inflammatory agents
RESVERLOGIX CORP1 citations72
US10532054B2Jan 14, 2020
Compounds for the prevention and treatment of cardiovascular diseases
RESVERLOGIX CORP2 citations72
US10131640B2Nov 20, 2018
Anti-inflammatory agents
RESVERLOGIX CORP1 citations62
US10111885B2Oct 30, 2018
Compositions and therapeutic methods for the treatment of complement-associated diseases
RESVERLOGIX CORP3 citations61
US10772894B2Sep 15, 2020
Compositions and therapeutic methods for the treatment of complement-associated diseases
RESVERLOGIX CORP1 citations54
US12551484B2Feb 17, 2026
Methods of treatment and/or prevention of major adverse cardiovascular events (MACE) with a combination of a BET bromodomain inhibitor and a sodium dependent glucose transport 2 inhibitor
RESVERLOGIX CORP0 citations50
US10016426B2Jul 10, 2018
Pharmaceutical compositions for substituted quinazolinones
RESVERLOGIX CORP0 citations45